Obesity Clinical Trials in New York, New York
35 recruitingNew York, New York
Showing 1–20 of 35 trials
Recruiting
Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ObesityHeart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction
Amgen5,056 enrolled596 locationsNCT07037459
Recruiting
Phase 3
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
ObesityOverweight
Eli Lilly and Company600 enrolled35 locationsNCT07357415
Recruiting
Phase 3
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ulcerative ColitisObesity or Overweight
Eli Lilly and Company350 enrolled191 locationsNCT06937086
Recruiting
Phase 3
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
ObesityOverweight
Eli Lilly and Company900 enrolled178 locationsNCT07392190
Recruiting
Phase 3
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Crohn's DiseaseObesity or Overweight
Eli Lilly and Company290 enrolled187 locationsNCT06937099
Recruiting
Phase 1
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Insulin ResistanceNon-Alcoholic Fatty Liver DiseaseOverweight and Obesity+1 more
Columbia University32 enrolled1 locationNCT06354088
Recruiting
Not Applicable
Reducing Obesity Using Social Ties Program
Obesity
Weill Medical College of Cornell University264 enrolled1 locationNCT06335810
Recruiting
Phase 3
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
ObesityOverweight
Eli Lilly and Company250 enrolled31 locationsNCT07232719
Recruiting
Not Applicable
High Fructose Diet, the Gut Microbiome, and Metabolic Health
ObesityMASLDType 2 Diabetes
Icahn School of Medicine at Mount Sinai30 enrolled1 locationNCT06329544
Recruiting
Phase 1
Graded Insulin Suppression Test P&F
ObesityInsulin ResistanceHealthy+1 more
Columbia University15 enrolled1 locationNCT06592261
Recruiting
Phase 1
Diazoxide Suppression Test P&F Study
ObesityInsulin ResistanceHyperinsulinemia
Columbia University10 enrolled1 locationNCT06606327
Recruiting
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
Childhood ObesityMorbid Obesity
Columbia University12 enrolled2 locationsNCT02602769
Recruiting
Not Applicable
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
ObesityAcute Lymphoblastic Leukemia
Columbia University376 enrolled1 locationNCT05963971
Recruiting
Not Applicable
Effects of Ultra Processed Food on Intestinal Energy Harvest
Obesity and Overweight
Columbia University20 enrolled1 locationNCT06853288
Recruiting
Not Applicable
Impact of Yo-Yo Sleep on Cardiometabolic Health
ObesityCardiometabolic Syndrome
Columbia University72 enrolled1 locationNCT05880758
Recruiting
Phase 4
Weight Loss Study: Genetics and Response to Naltrexone/Bupropion
Obesity
Columbia University120 enrolled1 locationNCT05919797
Recruiting
Not Applicable
Intervention INC: An Interactive Family-centered mHealth Tool to Reduce Obesity Risk in Urban Minority Preadolescents
Obesity, Childhood
Tufts University200 enrolled2 locationsNCT05935592
Recruiting
Chronic Widespread Pain After Rapid Weight Loss in Non-Hispanic Black and Hispanic/Latino/a/x Adults
ObesityBariatric Surgery CandidateChronic Pain, Widespread
New York University60 enrolled3 locationsNCT06795386
Recruiting
Not Applicable
RESET System Pivotal Trial (Rev F)
ObesityDiabetes type2
Morphic Medical Inc.264 enrolled7 locationsNCT04101669
Recruiting
Phase 2
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
ObesityB-cell Acute Lymphoblastic Leukemia
Etan Orgel240 enrolled20 locationsNCT05082519